La tunisie Medicale - 2022 ; Vol 100 ( n°01 ) : 49-55
[ 7790 times seen ]

Introduction: Multiple scores have been developed to assess the severity of psoriasis, but these scores have many limitations. The Simplified Psoriasis Index (SPI) is a summary score with separate components for current severity (SPI-s), psychosocial impact (SPI-p), and past history and interventions (SPI-i). It is available in two similar versions: proSPI and saSPI.
Aim: To assess the validity of the SPI by studying its correlation to the benchmark scores in Tunisian patients.
Methods: It was a prospective bicentric study including 80 patients with plaque psoriasis.
Results: The median PASI was 7.6 and the median DLQI was 9. The median proSPI-s was 6 and the median saSPI-s was 8. The median SPI-p was 7. The median SPI-i was 2. There was a strong correlation between the proSPI-s and PASI (r=0.87) and between the proSPI-s and saSPI-s (r=0.82). There was a medium correlation between saSPI-s and PASI (r=0.70) and between SPI-p and DLQI (r=0.67). The threshold value for proSPI-s and saSPI-s was 7.25. The threshold value for SPI-p was 6.5.
Conclusion: The SPI aims to provide a concise but global measure of the severity and impact of psoriasis on quality of life. The use of SPI has several advantages: the simplicity of use, the additional weight given to critical locations of psoriasis, the possibility for the patient to self-assess his own disease, and the possibility of evaluating all the dimensions of psoriasis at the same time.

Key - Words
  1. Richard MA, Aractingi S, Joly P, et al. French adaptation of a new score for global assessment of psoriasis severity: The Simplified Psoriasis Index (SPI). Ann Dermatol Venereol 2019;146(12 Suppl):783–92.
  2. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19(3 Suppl):210-6.
  3. Naldi L. Scoring and monitoring the severity of psoriasis. What is the preferred method? What is the ideal method? Is PASI passé? facts and controversies. Clin Dermatol 2010;28:67-72
  4. Hsu S, Papp KA, Lebwohl MG, et al. Consensus guidelines for the management of plaque psoriasis. Arch Dermatol 2012;148(1 Suppl):95–102.
  5. Chularojanamontri L, Griffiths CEM, Chalmers RJG. The Simplified Psoriasis Index (SPI): a practical tool for assessing psoriasis. J Invest Dermatol 2013;133:1956-62.
  6. Chalmers RJ. Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. Dermatol Clin 2015;33:57–71.
  7. Van Geel MJ, Otero ME, De Jong EM, Van De Kerkhof PC, Seyger MM. Validation of the Simplified Psoriasis Index in Dutch children and adolescents with plaque psoriasis. Br J Dermatol 2017;176(3 Suppl):771–6.
  8. Morais MR, Martins GA, Romiti R, Tonoli RE, Carvalho AVE. Translation and validation of the Simplified Psoriasis Index (SPI) into Brazilian Portuguese. An Bras Dermatol 2018;93:813–8.
  9. Soliman M. Patient-Reported Disease Severity and Quality of Life Among Arabic Psoriatic Patients: A Cross-Sectional Survey. Clin Cosmet Investig Dermatol 2020;13:601-9.
  10. Mokkink LB, Terwee CB, Knol DL, Stratford PW, Alonso J, Patrick DL, et al. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol 2010;10:22.
  11. European Medicines Agency. (2004) Guideline on clinical investigation of medicinal products indicated for the treatment of psoriasis [WWW document]. Available from: http://www. guideline/2009/09/WC500003329.pdf.
  12. Finlay AY. Current severe psoriasis and the rule of tens. Br J Dermatol 2005;152(5 Suppl):861–7.
  13. Spuls PI, Lecluse LL, Poulsen ML, Bos JD, Stern RS, Nijsten T. How good are clinical severity and outcome measures for psoriasis?: quantitative evaluation in a systematic review. J Invest Dermatol 2010;130(4 Suppl):933–43.
  14. Chalmers RJ. Assessing psoriasis severity and outcomes for clinical trials and routine clinical practice. Dermatol Clin 2015;33:57–71.
  15. Ramsay B, Lawrence CM. Measurement of involved surface area in patients with psoriasis. Br J Dermatol 1991;124:565–70.
  16. Chularojanamontri L, Griffiths CEM, Chalmers RJG. Responsiveness to change and interpretability of the simplified psoriasis index. J Invest Dermatol 2014;134(2 Suppl):351-8
  17. Meah N, Alsharqi A, Azurdia RM, Owens LC, Parslew R, Chularojanamontri L. Assessing the validity and response distribution of the simplified psoriasis index in patients receiving phototherapy. Australas J Dermatol 2018;59:41-7.
E-mail :
Password :
Remember Me Forgot password? Sign UP
Keywords most used
Tunisia treatment Child diagnosis surgery prognosis epidemiology Risk factors Children prevalence Crohn’s disease Breast cancer Cancer obesity screening
Sign up to receive our newsletter
E-mail :
Stay in Touch
Join Us! !